EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor Prognosis
Mingda Zhu et al · Wiley · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, M. Z. E. (2026). EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor Prognosis. https://doi.org/10.1155/genr/8242640
MLA
al, Mingda Zhu et. "EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor Prognosis." 2026. https://doi.org/10.1155/genr/8242640.
Chicago
al, Mingda Zhu et. 2026. "EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor Prognosis.". https://doi.org/10.1155/genr/8242640.
Harvard
al, M. Z. E. 2026, EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor Prognosis, Wiley, available at: https://doi.org/10.1155/genr/8242640 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor Prognosis
- Autor / colaboradores
- Mingda Zhu et al
- Editorial
- Wiley
- Año de publicación
- 2026
- ISSN
- 1469-5073
- ISSN
- 1469-5073
- Idioma
- eng